Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome

Leukemia Research

Volumn 30, Issue 11, 2006, Pages 1347-1353

  Hofmann, W K ^a,b   Takeuchi, S ^b   Takeuchi, N ^b   Thiel, E ^a   Hoelzer, D ^c   Koeffler, H P ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

CD34 cells; Cell cycle control; DNA methylation; Gene expression; Myelodysplastic syndrome

Indexed keywords

CD34 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P14ARF; PROTEIN P15; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MISMATCH REPAIR; MYELODYSPLASTIC SYNDROME; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE;

ADULT; AGED; ANTIGENS, CD34; BONE MARROW CELLS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; DNA MISMATCH REPAIR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33748119844     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.03.015     Document Type: Article

References (17)

1. Hofmann W.K., Lubbert M., Hoelzer D., and Phillip K.H. Myelodysplastic syndromes. Hematol J 5 1 (2004) 1-8
2. Hofmann W.K., Miller C.W., Tsukasaki K., Tavor S., Ikezoe T., Hoelzer D., et al. Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias. Leuk Res 25 4 (2001) 333-338
3. Dasika G.K., Lin S.C., Zhao S., Sung P., Tomkinson A., and Lee E.Y. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 18 55 (1999) 7883-7899
4. Nakamaki T., Bartram C., Seriu T., Kahan J., Fukuchi K., Tsuruoka N., et al. Molecular analysis of the cyclin-dependent kinase inhibitor genes, p15, p16, p18 and p19 in the myelodysplastic syndromes. Leuk Res 21 3 (1997) 235-240
5. Uchida T., Kinoshita T., Nagai H., Nakahara Y., Saito H., Hotta T., et al. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes. Blood 90 4 (1997) 1403-1409
6. Quesnel B., Guillerm G., Vereecque R., Wattel E., Preudhomme C., Bauters F., et al. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood 91 8 (1998) 2985-2990
7. Herman J.G., Civin C.I., Issa J.P., Collector M.I., Sharkis S.J., and Baylin S.B. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 57 5 (1997) 837-841
8. Esteller M., Hamilton S.R., Burger P.C., Baylin S.B., and Herman J.G. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59 4 (1999) 793-797
9. 6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst 94 1 (2002) 26-32
10. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349 21 (2003) 2042-2054
11. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93 18 (1996) 9821-9826
12. Hofmann W.K., de Vos S., Tsukasaki K., Wachsman W., Pinkus G.S., Said J.W., et al. Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood 98 3 (2001) 787-794
13. Peters U.R., Tschan M.P., Kreuzer K.A., Baskaynak G., Lass U., Tobler A., et al. Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis. Cancer Res 59 17 (1999) 4233-4236
14. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25 2 (2000) 169-193
15. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 6 (1997) 2079-2088
16. Teofili L., Rutella S., Chiusolo P., La Barbera E.O., Rumi C., Ranelletti F.O., et al. Expression of p15INK4B in normal hematopoiesis. Exp Hematol 26 12 (1998) 1133-1139
17. Howe R.B., Porwit-MacDonald A., Wanat R., Tehranchi R., and Hellstrom-Lindberg E. The WHO classification of MDS does make a difference. Blood 103 9 (2004) 3265-3270